Hogy Medical Co.,Ltd. (TYO:3593)
6,700.00
+10.00 (0.15%)
Feb 13, 2026, 3:30 PM JST
Hogy Medical Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Cash & Equivalents | 17,758 | 22,005 | 19,419 | 18,862 | 14,364 | 20,549 |
Cash & Short-Term Investments | 18,284 | 22,005 | 19,419 | 18,862 | 14,364 | 20,549 |
Cash Growth | -13.87% | 13.32% | 2.95% | 31.31% | -30.10% | -12.10% |
Receivables | 12,821 | 11,445 | 12,765 | 11,962 | 11,340 | 11,390 |
Inventory | 9,422 | 9,944 | 9,455 | 8,867 | 8,810 | 8,804 |
Other Current Assets | 1,254 | 806 | 1,386 | 599 | 776 | 579 |
Total Current Assets | 41,781 | 44,200 | 43,025 | 40,290 | 35,290 | 41,322 |
Property, Plant & Equipment | 43,972 | 45,763 | 45,712 | 51,555 | 52,759 | 52,794 |
Long-Term Investments | 6,470 | 7,253 | 10,544 | 9,304 | 9,177 | 9,401 |
Other Intangible Assets | 565 | 377 | 495 | 819 | 1,536 | 1,951 |
Long-Term Deferred Tax Assets | - | 301 | 263 | 210 | 204 | 175 |
Other Long-Term Assets | 1,694 | 1 | 2 | 2 | 1 | 1 |
Total Assets | 94,482 | 97,895 | 100,041 | 102,180 | 98,967 | 105,644 |
Accounts Payable | 3,249 | 4,765 | 4,834 | 4,813 | 4,336 | 4,615 |
Accrued Expenses | - | 528 | 534 | 508 | 478 | 520 |
Short-Term Debt | - | 120 | 155 | 1,223 | 337 | 266 |
Current Portion of Long-Term Debt | 1,999 | 1,999 | 1,999 | 1,999 | 1,999 | 64 |
Current Income Taxes Payable | - | 1,506 | 233 | 1,564 | 1,608 | 1,470 |
Other Current Liabilities | 2,574 | 1,463 | 486 | 1,027 | 590 | 655 |
Total Current Liabilities | 7,822 | 10,381 | 8,241 | 11,134 | 9,348 | 7,590 |
Long-Term Debt | 10,170 | 11,670 | 3,669 | 5,668 | 7,667 | - |
Pension & Post-Retirement Benefits | 477 | 553 | 509 | 424 | 478 | 449 |
Long-Term Deferred Tax Liabilities | - | 299 | 942 | 546 | 927 | 1,145 |
Other Long-Term Liabilities | 1,533 | 661 | 562 | 730 | 552 | 509 |
Total Liabilities | 20,002 | 23,564 | 13,923 | 18,502 | 18,972 | 9,693 |
Common Stock | 7,123 | 7,123 | 7,123 | 7,123 | 7,123 | 7,123 |
Additional Paid-In Capital | 8,294 | 8,294 | 8,294 | 8,270 | 8,336 | 8,336 |
Retained Earnings | 56,536 | 56,552 | 67,762 | 91,142 | 88,523 | 86,149 |
Treasury Stock | -3,910 | -3,909 | -3,217 | -27,561 | -27,561 | -8,902 |
Comprehensive Income & Other | 6,429 | 6,263 | 6,148 | 4,632 | 3,537 | 3,172 |
Total Common Equity | 74,472 | 74,323 | 86,110 | 83,606 | 79,958 | 95,878 |
Minority Interest | 8 | 8 | 8 | 72 | 37 | 73 |
Shareholders' Equity | 74,480 | 74,331 | 86,118 | 83,678 | 79,995 | 95,951 |
Total Liabilities & Equity | 94,482 | 97,895 | 100,041 | 102,180 | 98,967 | 105,644 |
Total Debt | 12,169 | 13,789 | 5,823 | 8,890 | 10,003 | 330 |
Net Cash (Debt) | 6,115 | 8,216 | 13,596 | 9,972 | 4,361 | 20,219 |
Net Cash Growth | -13.40% | -39.57% | 36.34% | 128.66% | -78.43% | -10.65% |
Net Cash Per Share | 283.58 | 367.28 | 560.24 | 411.10 | 152.68 | 668.80 |
Filing Date Shares Outstanding | 21.56 | 21.56 | 24.27 | 24.26 | 24.26 | 29.59 |
Total Common Shares Outstanding | 21.56 | 21.56 | 24.27 | 24.26 | 24.26 | 30.12 |
Working Capital | 33,959 | 33,819 | 34,784 | 29,156 | 25,942 | 33,732 |
Book Value Per Share | 3454.22 | 3447.29 | 3547.40 | 3446.68 | 3296.27 | 3182.95 |
Tangible Book Value | 73,907 | 73,946 | 85,615 | 82,787 | 78,422 | 93,927 |
Tangible Book Value Per Share | 3428.01 | 3429.80 | 3527.00 | 3412.92 | 3232.95 | 3118.19 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.